Inflammation Memories in Stem Cells: Long-Lasting Heightened Sensitivity

The skin, often our first line of defense, doesn’t simply heal and move on from inflammation. It appears to retain a “memory” of past inflammatory events, a phenomenon now being linked to specific features within our DNA. New research, published March 26, 2026, in Science, sheds light on how these cellular memories form and, crucially, how long they last. Understanding the longevity of these memories could unlock new approaches to treating chronic inflammatory skin conditions like psoriasis and atopic dermatitis, where flares often recur in the same locations.

How Inflammation Leaves a Lasting Mark

Researchers have long observed that skin stem cells can “remember” inflammation, preparing for quicker healing in future injuries. Still, when this process goes awry, it can lead to chronic inflammation – a state of persistent hypersensitivity. The new study, conducted by researchers examining mice, pinpointed specific epigenetic signatures associated with the duration of these cellular memories. Epigenetics refers to changes in gene expression – how genes are “read” – without altering the underlying DNA sequence itself. These changes can be influenced by environmental factors, like inflammation, and can be passed down through cell divisions.

The team monitored epigenetic changes in epidermal stem cells over two years following an induced bout of psoriasis in young mice. This long-term observation period was critical, as it allowed them to identify the DNA sequences linked to the persistence of inflammatory memory. The findings suggest that certain epigenetic modifications act as a kind of cellular record, maintaining a heightened state of alert even long after the initial inflammatory trigger has subsided.

Beyond Skin: Inflammation and Cellular Memory Across the Body

Although this research focused on skin inflammation, the concept of cellular memory isn’t limited to dermatology. Chronic inflammatory conditions, such as rheumatoid arthritis and inflammatory bowel disease, share similar characteristics of recurring flares and persistent immune activation. A separate study, published in Nature in early March 2026, demonstrated that a Smad7-based biologic accelerates diabetic wound healing by improving epithelial regeneration and reducing inflammatory neutrophil activity. The study, conducted on both mice and pigs, highlights the potential of targeting specific pathways to modulate inflammatory responses and promote tissue repair. This suggests that the principles governing cellular memory and inflammation may be broadly applicable across different tissues, and diseases.

What Does This Indicate for Treatment?

The identification of specific epigenetic signatures opens up potential avenues for therapeutic intervention. Currently, treatments for chronic inflammatory conditions often rely on broad immunosuppressants, which can have significant side effects. A more targeted approach, aimed at modulating the epigenetic mechanisms underlying cellular memory, could offer a more precise and effective way to manage these conditions. For example, researchers are exploring the use of extracellular vesicles (EVs) derived from neural stem cells to alleviate inflammation. Research indicates that these EVs can decrease the expression of pro-inflammatory cytokines and improve skin barrier integrity in models of atopic dermatitis.

However, it’s important to note that this research is still in its early stages. The study was conducted in mice, and further research is needed to determine whether the same mechanisms operate in humans. The epigenetic landscape is incredibly complex, and manipulating it carries potential risks. Any therapeutic strategy targeting epigenetic modifications would need to be carefully evaluated for safety and efficacy.

The Role of Neutrophils and Keratinocytes in Wound Healing

The Nature study on Smad7-based biologics further illuminates the cellular players involved in chronic inflammation. Researchers found that keratinocytes (skin cells) and neutrophils (a type of immune cell) are key targets for Tat-PYC-Smad7, a Smad7-based biologic. The treatment reduced TGFβ/NFκB signaling, accelerated re-epithelialization, and attenuated neutrophil extracellular trap (NET) formation. NETs are web-like structures released by neutrophils that can contribute to inflammation and tissue damage. Reducing NET formation, potentially by modulating MPO enzymatic activity, appears to be a crucial mechanism by which Tat-PYC-Smad7 promotes wound healing.

Understanding Epigenetics: A Simplified Explanation

Imagine your DNA as a cookbook containing all the recipes for building and maintaining your body. Epigenetics are like sticky notes placed on certain recipes, marking them as “often used” or “rarely used.” These sticky notes don’t change the recipes themselves, but they influence how often they are followed. In the context of inflammation, epigenetic modifications can alter the expression of genes involved in immune responses, making cells more or less sensitive to inflammatory triggers. These modifications can be inherited when cells divide, effectively passing down the “memory” of inflammation to subsequent generations of cells.

What Comes Next: Refining Therapies and Expanding Research

The research community is now focused on several key areas. Further studies are needed to validate these findings in human models and to identify the specific epigenetic modifications that are most strongly associated with chronic inflammation. Researchers are also exploring the development of new therapeutic strategies that can selectively target these modifications, potentially offering a more precise and effective way to manage inflammatory diseases. The RNA-seq data generated in the Smad7 study is publicly available in the Gene Expression Omnibus (GSE274513), and mass spectrometry data is available in MassIVE (MSV000095545), providing valuable resources for other researchers in the field. Continued investigation into the complex interplay between epigenetics, inflammation, and cellular memory promises to yield new insights into the pathogenesis of chronic diseases and pave the way for more effective treatments.